Literature DB >> 16133158

[Relevance of the neuroendocrine differentiation in prostatic carcinoma].

C G Sauer1, L Trojan, R Grobholz.   

Abstract

BACKGROUND: NE tumor cells are present in virtually all prostatic adenocarcinomas. As they express no androgen receptor they are hormone independent. During anti-androgenic therapy their number increases. Their prognostic value is controversial.
MATERIAL AND METHODS: In 233 patients with prostatic carcinoma the NE differentiation was determined in a hot spot (7.9 mm(2)) with maximum CgA positive cell density. A high NE differentiation (HNE) was defined by a least 30 NE tumor cells, while less means a low NE differentiation (LNE). In addition the occurrence of NE tumor cells was defined as solitary or clustered (> or =5 NE tumor cells in close proximity).
RESULTS: In advanced and high grade tumors more and clustered NE tumor cells could be found than in low grade and organ confined tumors. Moreover HNE tumors and occurrence of NE clusters resulted in a significant shorter progression-free interval.
CONCLUSIONS: Besides the quantity of NE differentiation the quality of the growth pattern of NE tumor cells is of relevance in prostatic carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133158     DOI: 10.1007/s00292-005-0784-z

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  27 in total

1.  Correlation between neovascularisation and neuroendocrine differentiation in prostatic carcinoma.

Authors:  R Grobholz; M H Bohrer; M Siegsmund; K P Jünemann; U Bleyl; M Woenckhaus
Journal:  Pathol Res Pract       Date:  2000       Impact factor: 3.250

2.  Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy.

Authors:  M H Weinstein; A W Partin; R W Veltri; J I Epstein
Journal:  Hum Pathol       Date:  1996-07       Impact factor: 3.466

Review 3.  Neuroendocrine cells in tumour growth of the prostate.

Authors:  P A Abrahamsson
Journal:  Endocr Relat Cancer       Date:  1999-12       Impact factor: 5.678

4.  Development of human prostate cancer cells to neuroendocrine-like cells by interleukin-1.

Authors:  J W Chiao; T C Hsieh; W Xu; R J Sklarew; R Kancherla
Journal:  Int J Oncol       Date:  1999-11       Impact factor: 5.650

5.  Prognostic significance of neuroendocrine differentiation, proliferation activity and androgen receptor expression in prostate cancer.

Authors:  N Segawa; I Mori; H Utsunomiya; M Nakamura; Y Nakamura; L Shan; K Kakudo; Y Katsuoka
Journal:  Pathol Int       Date:  2001-06       Impact factor: 2.534

6.  Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo.

Authors:  T Burchardt; M Burchardt; M W Chen; Y Cao; A de la Taille; A Shabsigh; O Hayek; T Dorai; R Buttyan
Journal:  J Urol       Date:  1999-11       Impact factor: 7.450

7.  Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma.

Authors:  E Bollito; A Berruti; M Bellina; A Mosca; E Leonardo; R Tarabuzzi; S Cappia; M M Ari; M Tampellini; D Fontana; L Gubetta; A Angeli; L Dogliotti
Journal:  Ann Oncol       Date:  2001       Impact factor: 32.976

8.  Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP.

Authors:  Y J Bang; F Pirnia; W G Fang; W K Kang; O Sartor; L Whitesell; M J Ha; M Tsokos; M D Sheahan; P Nguyen; W T Niklinski; C E Myers; J B Trepel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

9.  Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate.

Authors:  H Bonkhoff; U Stein; K Remberger
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 10.  Neuroendocrine differentiation in human prostatic carcinoma.

Authors:  P A di Sant'Agnese
Journal:  Hum Pathol       Date:  1992-03       Impact factor: 3.466

View more
  1 in total

1.  [Neuroendocrine tumors].

Authors:  W Saeger
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.